safety profile – Page 2

Gilead and Arcellx Present Promising CAR-T Therapy Data for Advanced Multiple Myeloma, Highlighting Safety and Efficacy Against Carvykti

12 months ago talkbio0Tagged 2024, Arcellx, Asymmetric Septal Hypertrophy, CAR-T, Carvykti, Effectiveness, Gilead, Multiple Myeloma, relapsed/refractory multiple myeloma, safety profile

Gilead, Arcellx, CAR-T therapy, multiple myeloma, anito-cel, Carvykti, ASH 2024, safety profile, efficacy, relapsed/refractory multiple myeloma

Gilead and Arcellx Highlight Promising CAR T Therapy for Multiple Myeloma with Enhanced Safety Profile

12 months ago talkbio0Tagged Arcellx, Automobiles, Clinical Trials, Effectiveness, Gilead, Multiple Myeloma, safety profile, T therapy

CAR T therapy, multiple myeloma, anito-cel, Gilead, Arcellx, safety profile, efficacy, clinical trials

Exsilio Therapeutics Launches with $82 Million to Develop mRNA-Based Genomic Medicines Under Tal Zaks’ Leadership

1 year ago talkbio0Tagged Approved, Exsilio, Gene Modification, gene therapy, genomic medicines, Lipids, nanoparticle delivery, RNA, Messenger, safety profile, Tal Zaks

Exsilio Therapeutics, mRNA, genomic medicines, Tal Zaks, gene therapy, gene editing, lipid nanoparticle delivery, redosing, safety profile, gene therapy approval

Axsome Therapeutics’ Small Molecule AXS-12 Successful in Phase III Narcolepsy Trial

2 years ago talkbio0Tagged AXS-12, Axsome, Cataplexy, Drowsiness, Improved, memory/, Narcolepsy, Phase 3 Clinical Trials, reboxetine, safety profile, Severities

Axsome Therapeutics, AXS-12 (reboxetine), Phase III trial, Narcolepsy, Cataplexy reduction, Improved cognition/ memory/ sleepiness severity, Safety profile